| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |